Test Price
3,000 AEDโ Home Collection Available
Comprehensive Dysmorphology NGS Panel Genetic Test in UAE | 3000 AED
Executive Summary & Core Metrics
- โ Diagnostic Accuracy: 99.9% diagnostic sensitivity for targeted gene mutations using advanced NGS technology.
- โ Rapid Turnaround: Results delivered within 3โ4 weeks from sample receipt.
- โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection: Available daily from 8 AM to 11 PM for standard blood draws.
- โ Clinical Guidance: Post-result telephonic consultation with a specialist genetic counselor to explain findings.
- โ Price: 3,000 AED inclusive of genetic analysis and clinical report.
- โ DHA Licensed: Facility License No. 1143, Dubai Healthcare City.
Test Overview & Methodology
This comprehensive Next-Generation Sequencing (NGS) panel analyzes over 300 genes associated with syndromic and non-syndromic dysmorphology. It is designed to provide a precise molecular diagnosis for complex congenital anomalies, aiding clinicians in targeted management and family counseling.
The methodology uses deep-coverage NGS to detect single nucleotide variants (SNVs), small insertions/deletions (indels), and copy number variants (CNVs) across a curated gene list relevant to dysmorphic syndromes. Results are interpreted against the latest ACMG/AMP standards.
| Feature | Our Dysmorphology NGS Panel | Chromosomal Microarray (CMA) |
|---|---|---|
| Clinical Precision | 99.9% diagnostic sensitivity for targeted gene mutations | ~85โ90% sensitivity, limited to copy number variants |
| Methodology | NGS with deep coverage; comprehensive gene panel | Microarray-based CNV detection; no sequence-level mutations |
| Turnaround Time | 3โ4 Weeks | 2โ3 Weeks |
| Diagnostic Yield in Dysmorphology | Superior for monogenic syndromes, undiagnosed rare diseases | Good for large deletions/duplications, lower yield for single-gene disorders |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403: โAs a medical geneticist, I see this panel as a critical tool for families seeking answers about congenital differences. The comprehensive gene coverage provides a high diagnostic yield, particularly in complex dysmorphic cases. However, results must always be integrated with a full clinical evaluation, including dysmorphology exam and three-generation pedigree. A negative result does not exclude all genetic conditions, and non-genetic causes should be considered. Genetic counseling is essential to interpret findings accurately and guide future reproductive decisions.โ
Important Advisory for Patients and Clinicians
This test is intended for individuals with clinical features suggestive of a genetic syndrome. It is not a routine screening test for asymptomatic individuals. All results must be correlated with clinical findings. If the patient is on anticoagulant therapy, special sample handling precautions are neededโplease inform the phlebotomist. Do not discontinue any prescribed medication without consulting your physician.
Exclusion Criteria & Red Flags
- Not suitable for asymptomatic individuals without clinical dysmorphic features or for general population screening.
- If the patient develops acute respiratory distress, uncontrolled seizures, severe hypotonia with regression, or life-threatening events, seek immediate emergency care. This test is not a substitute for urgent medical assessment.
Patient FAQ & Clinical Guidance
1. What is the Dysmorphology Panel used for?
It is used to detect mutations in over 300 genes known to cause congenital anomalies, helping confirm a precise molecular diagnosis. The test covers a wide range of genes associated with growth disorders, skeletal abnormalities, facial dysmorphism, and neurodevelopmental conditions, enabling doctors to direct medical and genetic care appropriately.
2. How should I prepare my child for the blood sample collection?
The sample is collected through a simple venous blood draw. No fasting or special preparation is required. Parents may stay with the child during collection for comfort. Home collection service is available to avoid the stress of traveling to a lab.
3. When will I receive the results and how will they be interpreted?
Results are available within 3โ4 weeks. A telephonic consultation with a medical geneticist is included to explain the findings, assess risks, and provide appropriate medical recommendations. The interpretation follows international guidelines to ensure accuracy.
UAE Regulatory & Data Privacy Adherence
Compliance with UAE Federal Laws
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, securely stored, and accessible only to authorized clinical personnel. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is DHA-licensed (License No. 1143) and strictly follows ISO standards for laboratory quality and data governance.
Clinical & Logistical Metadata
| Test Name | Dysmorphology Panel Genetic Test (NGS) |
| Price (AED) | 3,000 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3-5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) with deep coverage |
| ICD-10-CM Code | Q87.89 |
| LOINC Code | 94231-1 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians